Heavy-Atom-Free Photosensitizer-Loaded Lipid Nanocapsules for Photodynamic Therapy

Photodynamic therapy (PDT) is a clinically approved noninvasive treatment for cancer that employs a photosensitizer (PS) to generate cytotoxic reactive singlet oxygen (ROS) species that precisely destroy cancer cells at the targeted tumor sites. There is growing interest in the development of innovative photosensitizing agents and advanced delivery methods, offering superior phototherapeutic performance. The delivery of PS is a challenging task in PDT in regard to the high hydrophobicity of the PS molecule. To address this challenge, the incorporation of heavy-atom-free PS (HAF-PS) in effective drug delivery carriers is promising for PDT improvement. Herein, we propose a strategy to encapsulate the HAF-PS from the perylenediimide (PDI) family in the oily core of lipid nanocapsules (LNCs). The resulting HAF-PS-loaded LNCs formulations have the advantage to efficiently generate singlet oxygen (<sup>1</sup>O<sub>2</sub>) in a biorelevant environment. The LNCs formulations loaded with <b>O-PDI</b> (<b>O-PDI@LNC</b>) and <b>1S-PDI</b> (<b>1S-PDI@LNC</b>) were obtained by a solvent-free phase-inversion temperature (PIT) method. Our study demonstrates that optimized LNCs formulation loaded with <b>1S-PDI</b> acting as PS is a highly efficient approach to deliver phototherapeutic agents for PDT. Overall, it has been shown that illumination of <b>1S-PDI</b> leads to dramatic <sup>1</sup>O<sub>2</sub> production with an impressive quantum yield (<i>φSOQY</i> = 0.94) which was tested with 1,3-diphenylisobenzofuran (<b>DPBF</b>) as a specific trap. Moreover, the <sup>1</sup>O<sub>2</sub> generation was calculated in a phosphate buffer solution (<i>φSOQY</i> = 0.52) for loaded nanocarrier <b>1S-PDI@LNC</b>. <i>In vitro</i> cytotoxicity studies demonstrated a low dark toxicity of <b>1S-PDI@LNC</b> while illumination significantly enhanced its photocytotoxicity in cells. Furthermore, the cellular internalization of LNCs was demonstrated in U-87 MG cells using <b>O-PDI@LNC</b> as a model, exploiting the excellent fluorescence properties of <b>O-PDI</b>. This study has significant potential for advancing the development of HAF-PS-loaded LNCs for minimally invasive PDT.

Authors

Institutions

Publication Details

Journal
ACS Applied Bio Materials
Published
2025-03-20
DOI
https://doi.org/10.1021/acsabm.4c01953
Citations
9
Primary Topic
Nanoplatforms for cancer theranostics
Type
article
Field-Weighted Citation Impact
6.07

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Heavy-Atom-Free Photosensitizer-Loaded Lipid Nanocapsules for Photodynamic Therapy

Oksana Krupka, Guillaume Bastiat, Isabelle Verdu, Piétrick Hudhomme et al.
9 citations
ACS Applied Bio Materials
Nanoplatforms for cancer theranostics
6.07
article

Heavy-Atom-Free Photosensitizer-Loaded Lipid Nanocapsules for Photodynamic Therapy

Oksana Krupka, Guillaume Bastiat, Isabelle Verdu, Piétrick Hudhomme, Julien Gouju, Catherine Passirani, Patrick Saulnier, Oksana Kharchenko
article en
9 citations

Abstract

Photodynamic therapy (PDT) is a clinically approved noninvasive treatment for cancer that employs a photosensitizer (PS) to generate cytotoxic reactive singlet oxygen (ROS) species that precisely destroy cancer cells at the targeted tumor sites. There is growing interest in the development of innovative photosensitizing agents and advanced delivery methods, offering superior phototherapeutic performance. The delivery of PS is a challenging task in PDT in regard to the high hydrophobicity of the PS molecule. To address this challenge, the incorporation of heavy-atom-free PS (HAF-PS) in effective drug delivery carriers is promising for PDT improvement. Herein, we propose a strategy to encapsulate the HAF-PS from the perylenediimide (PDI) family in the oily core of lipid nanocapsules (LNCs). The resulting HAF-PS-loaded LNCs formulations have the advantage to efficiently generate singlet oxygen (<sup>1</sup>O<sub>2</sub>) in a biorelevant environment. The LNCs formulations loaded with <b>O-PDI</b> (<b>O-PDI@LNC</b>) and <b>1S-PDI</b> (<b>1S-PDI@LNC</b>) were obtained by a solvent-free phase-inversion temperature (PIT) method. Our study demonstrates that optimized LNCs formulation loaded with <b>1S-PDI</b> acting as PS is a highly efficient approach to deliver phototherapeutic agents for PDT. Overall, it has been shown that illumination of <b>1S-PDI</b> leads to dramatic <sup>1</sup>O<sub>2</sub> production with an impressive quantum yield (<i>φSOQY</i> = 0.94) which was tested with 1,3-diphenylisobenzofuran (<b>DPBF</b>) as a specific trap. Moreover, the <sup>1</sup>O<sub>2</sub> generation was calculated in a phosphate buffer solution (<i>φSOQY</i> = 0.52) for loaded nanocarrier <b>1S-PDI@LNC</b>. <i>In vitro</i> cytotoxicity studies demonstrated a low dark toxicity of <b>1S-PDI@LNC</b> while illumination significantly enhanced its photocytotoxicity in cells. Furthermore, the cellular internalization of LNCs was demonstrated in U-87 MG cells using <b>O-PDI@LNC</b> as a model, exploiting the excellent fluorescence properties of <b>O-PDI</b>. This study has significant potential for advancing the development of HAF-PS-loaded LNCs for minimally invasive PDT.

ACS Applied Bio MaterialsVol. 8(4)
Centre National de la Recherche Scientifique (FR), Inserm (FR), Institut des Sciences et Technologies Moléculaires d'Angers (FR), Université d'Angers (FR)
Agence Nationale de la Recherche, HORIZON EUROPE Marie Sklodowska-Curie Actions
Openalex Percentile: Top 4%
Nanoplatforms for cancer theranostics
6.07
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.